Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Having an mRNA COVID vaccine will not make your body produce new tumour-fighting T cells. What it might do, based on this ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Deborah Fuller, University of Washington (THE CONVERSATION) At a Sept. 4, 2025, ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

We know from previous research that both Covid infection and Covid mRNA vaccination are associated with the rare complication of myocarditis and pericarditis (heart inflammation) in children. A new ...

University of Florida researchers found that advanced lung and skin cancer patients lived “significantly longer” after ...

Moderna MRNA shares rallied 13.9% in the last trading session to close at $28.14. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.